The High-Stakes Gamble: Summit's Vision vs. Akeso's Strategic Play with Ivonesimab
Goldman Sachs Unveils Exclusive List of 48 Companies Primed for Acquisition Across Key Sectors
Market Movers Revealed: Unpacking Last Week's Large-Cap Triumphs!
Summit Therapeutics' Lung Cancer Hope Faces Fierce Competition and Scrutiny